WHO Chief Tedros Says Received First Expression Of Interest For Emergency Use Listing From Mpox Diagnostics Manufacturer; WHO Officials Discuss Polio Vaccination Plan In Gaza, Confirm Applications From Bavarian Nordic And KM Biologics For Mpox...
WHO Chief Tedros Says Received First Expression Of Interest For Emergency Use Listing From Mpox Diagnostics Manufacturer; WHO Officials Discuss Polio Vaccination Plan In Gaza, Confirm Applications From Bavarian Nordic And KM Biologics For Mpox...
世衛組織總幹事譚德塞表示，接到了來自Mpox診斷製造商的首個緊急使用上市的興趣表達；世衛組織官員討論加沙的脊髓灰質炎疫苗接種計劃，並確認了Bavarian Nordic和Km Biologics申請使用Mpox的疫苗急需上市，並宣佈剛果擁有23萬劑可用。
WHO Chief Tedros Says Received First Expression Of Interest For Emergency Use Listing From Mpox Diagnostics Manufacturer; WHO Officials Discuss Polio Vaccination Plan In Gaza, Confirm Applications From Bavarian Nordic And KM Biologics For Mpox Vaccines Emergency Use Listing, And Announce 230,000 Doses Available For Congo
世衛組織總幹事譚德塞表示，接到了來自Mpox診斷製造商的首個緊急使用上市的興趣表達；世衛組織官員討論加沙的脊髓灰質炎疫苗接種計劃，並確認了Bavarian Nordic和Km Biologics申請使用Mpox的疫苗急需上市，並宣佈剛果擁有23萬劑可用。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。